Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · IEX Real-Time Price · USD
0.529
+0.018 (3.44%)
At close: Mar 28, 2024, 4:00 PM
0.530
+0.001 (0.26%)
After-hours: Mar 28, 2024, 4:26 PM EDT
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $1.91 million as of March 28, 2024. Its market cap has decreased by -56.59% in one year.
Market Cap
1.91M
Enterprise Value
-3.70M
1-Year Change
-56.59%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since January 29, 2015, Salarius Pharmaceuticals's market cap has decreased from $254.50M to $1.91M, a decrease of -99.25%. That is a compound annual growth rate of -41.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 2.10M | - |
Mar 26, 2024 | 2.10M | -4.55% |
Mar 25, 2024 | 2.20M | -18.52% |
Mar 22, 2024 | 2.70M | 17.39% |
Mar 21, 2024 | 2.30M | -4.17% |
Mar 20, 2024 | 2.40M | -7.69% |
Mar 19, 2024 | 2.60M | 8.33% |
Mar 18, 2024 | 2.40M | -7.69% |
Mar 15, 2024 | 2.60M | 4.00% |
Mar 14, 2024 | 2.50M | 4.17% |
Mar 13, 2024 | 2.40M | -4.00% |
Mar 12, 2024 | 2.50M | -3.85% |
Mar 11, 2024 | 2.60M | -3.70% |
Mar 8, 2024 | 2.70M | 3.85% |
Mar 7, 2024 | 2.60M | -3.70% |
Mar 6, 2024 | 2.70M | - |
Mar 5, 2024 | 2.70M | 3.85% |
Mar 4, 2024 | 2.60M | - |
Mar 1, 2024 | 2.60M | - |
Feb 29, 2024 | 2.60M | - |
Feb 28, 2024 | 2.60M | 8.33% |
Feb 27, 2024 | 2.40M | - |
Feb 26, 2024 | 2.40M | 4.35% |
Feb 23, 2024 | 2.30M | 4.55% |
Feb 22, 2024 | 2.20M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Dynatronics | 2.13M |
InMed Pharmaceuticals | 2.08M |
Qualigen Therapeutics | 2.07M |
SciSparc | 2.04M |
Allarity Therapeutics | 1.93M |
NanoVibronix | 1.86M |
Bone Biologics | 1.79M |
NeuBase Therapeutics | 1.79M |